Blake Byers serves as Executive at Magenta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Blake Byers has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 25, 2018 involved exercising options for 3,339,137 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 25, 2018 | MGTA | $0 | Conversion | 3,339,137 | $N/A | Discretionary |
Blake Byers currently holds 3,339,137 shares of Magenta Therapeutics, Inc. (MGTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Blake Byers has been a net neutral trader of MGTA stock. They have purchased $0 and sold $0 worth of shares.
Blake Byers's most recent insider trade was on Jun 25, 2018, when they sold 3,339,137 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted